cjc1295 and aod9604 AOD-9604 | Lab-Tested Research Peptide UK CJC-1295 (No DAC) Peptide |

Its widely used in wellness, performance, and medical aesthetics clinics as part of recovery, fat-burning, and rejuvenation protocols

Negative Control of GHR Signaling Control of the GH signaling cascade is also under inhibitory control, principally by two mechanisms

20 in stock AOD 9604 5mg Modified Growth Hormone Fragment Research Peptide AOD 9604 is a modified 16-amino-acid synthetic peptide corresponding to the C-terminal fragment of human growth hormone (residues 177-191), with an additional tyrosine added to the N-terminus for stability

However, this clinical history does not extend any licensed status to the 10mg lyophilised research format, which is supplied strictly for laboratory investigation only